Neutrophil attractant protein-1-immunoglobulin G immune complexes and free anti-NAP-1 antibody in normal human serum
- PMID: 1644918
- PMCID: PMC443123
- DOI: 10.1172/JCI115883
Neutrophil attractant protein-1-immunoglobulin G immune complexes and free anti-NAP-1 antibody in normal human serum
Abstract
After obtaining data indicating the presence of a neutrophil attractant protein-1 (NAP-1)-IgG complex in normal human serum, we developed sandwich ELISAs that could quantify NAP-1 and NAP-1-IgG in mixtures of the two moieties. The ELISA for free NAP-1 used a monoclonal capture antibody that did not bind NAP-1-IgG. The ELISA for NAP-1-IgG was based on omission of the anti-NAP-1 detection antibody (required for the free NAP-1 ELISA) and on interaction of phosphatase-conjugated anti-human IgG with the human NAP-1-IgG complex. Gel filtration of immunoaffinity-purified NAP-1-IgG showed that the bulk of the complex comprised a single IgG. Binding between NAP-1 and antibody is strong, since 8 M urea at neutral or alkaline pH did not release NAP-1. However, at pH 2.0 in 9 M urea approximately 15% of the total NAP-1 could be dissociated from the complex. NAP-1-IgG was detected in 18 of 26 sera from normal humans. The mean serum concentration was 58 ng of IgG-bound NAP-1/ml, with an SEM of 16 and a range from undetectable to 247 ng/ml. NAP-1-IgG concentrations in paired sera drawn at a 1-mo interval were remarkably constant. Using an ELISA for free NAP-1 with a detection limit of 200 pg/ml, we found no free NAP-1 in the 26 sera. Free anti-NAP-1-IgG autoantibody was found in 9 of 26 sera by direct ELISA. IgG anti-NAP-1 of all nine sera was polyclonal, comprising both kappa and lambda isotypes; predominant subclasses were IgG2 and IgG3. NAP-1-IgG did not compete with 125I-NAP-1 for binding to neutrophils, which suggests that IgG anti-NAP-1 is a molecular trap that prevents binding of NAP-1 to neutrophils after it diffuses from production sites into the circulation.
Similar articles
-
Neutrophil attractant protein-1 and monocyte chemoattractant protein-1 in human serum. Effects of intravenous lipopolysaccharide on free attractants, specific IgG autoantibodies and immune complexes.J Immunol. 1993 Sep 15;151(6):3292-8. J Immunol. 1993. PMID: 8376779
-
Binding characteristics of dimeric IgG subclass complexes to human neutrophils.J Immunol. 1989 Apr 1;142(7):2359-64. J Immunol. 1989. PMID: 2784461
-
IgG antibodies to secretory component in normal human serum.J Immunol. 1984 Oct;133(4):2111-5. J Immunol. 1984. PMID: 6332148
-
Immunoglobulin bound to platelets as immune complexes or specific antibody in specimens from acquired immunodeficiency syndrome and immune thrombocytopenic purpura.Diagn Immunol. 1985;3(4):205-14. Diagn Immunol. 1985. PMID: 2935354
-
[Induction of biological activities by chemically modified subfragments from human serum IgG and their application to development of medicine].Yakugaku Zasshi. 1996 May;116(5):374-87. doi: 10.1248/yakushi1947.116.5_374. Yakugaku Zasshi. 1996. PMID: 9019527 Review. Japanese.
Cited by
-
Anti-Cytokine Autoantibodies in Systemic Lupus Erythematosus.Cells. 2019 Dec 27;9(1):72. doi: 10.3390/cells9010072. Cells. 2019. PMID: 31892200 Free PMC article. Review.
-
Role of elevated plasma soluble ICAM-1 and bronchial lavage fluid IL-8 levels as markers of chronic lung disease in premature infants.Thorax. 1995 Oct;50(10):1073-9. doi: 10.1136/thx.50.10.1073. Thorax. 1995. PMID: 7491556 Free PMC article.
-
The mercurial nature of neutrophils: still an enigma in ARDS?Am J Physiol Lung Cell Mol Physiol. 2014 Feb;306(3):L217-30. doi: 10.1152/ajplung.00311.2013. Epub 2013 Dec 6. Am J Physiol Lung Cell Mol Physiol. 2014. PMID: 24318116 Free PMC article. Review.
-
Chemotactic factors in cerebrospinal fluid during bacterial meningitis.Infect Immun. 2006 Mar;74(3):1445-51. doi: 10.1128/IAI.74.3.1445-1451.2006. Infect Immun. 2006. PMID: 16495514 Free PMC article. Review. No abstract available.
-
Anti-cytokine autoantibodies in autoimmunity: preponderance of neutralizing autoantibodies against interferon-alpha, interferon-omega and interleukin-12 in patients with thymoma and/or myasthenia gravis.Clin Exp Immunol. 2003 Apr;132(1):128-36. doi: 10.1046/j.1365-2249.2003.02113.x. Clin Exp Immunol. 2003. PMID: 12653847 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials